JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

The cardiovascular effects of sepsis.

Future therapies for septic shock will likely center around the antagonism of toxins released by the infecting organism and the modification of the host response to such toxins. Until such therapies become available, patient salvage will continue to depend on the maintenance of effective circulatory function until the source of infection is eliminated. With the recognition that resuscitation is best directed toward optimization of peripheral oxygen metabolism, reduction of mortality has been achieved in recent years through the early application of invasive hemodynamic monitoring and the aggressive manipulation of the determinants of peripheral oxygen delivery. Volume loading to improve myocardial performance, transfusion to increase the oxygen carrying capacity of the blood, intubation and mechanical ventilation to maximize arterial oxygen saturation, sedation to limit unnecessary peripheral oxygen use, and pharmacologic support of supranormal peripheral perfusion requirements are the essential tenets of successful management.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app